Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Condition : Osteoarthritis Intervention : Other: Swedish Massage Sponsors : Duke University; National Center for Complementary and Alternative Medicine (NCCAM) Completed - verified November 2013

Condition : Psoriatic Arthritis Interventions : Biological: AIN457; Drug: Placebo Sponsors : Novartis; Novartis Pharmaceuticals Recruiting - verified November 2013

Conditions : Systemic Lupus Erthematosus; Sjogren's Syndrome Interventions : Drug: Omalizumab; Drug: Placebo Sponsors : National Institutes of Health Clinical Center (CC); National Institute of Arthri...

Condition : Rheumatoid Arthritis Intervention : Biological: mavrilimumab subcutaneous Injection Sponsor : MedImmune LLC Recruiting - verified February 2014

This study is comprised of a 104 week treatment period beginning on Day 1 of study drug administration and a 30-day follow-up period or permanent termination of clinical development of the product, wh...

Condition : Rheumatoid Arthritis Interventions : Drug: Baricitinib; Drug: Methotrexate; Drug: Placebo; Drug: Folic Acid Sponsor : Eli Lilly and Company Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Baricitinib; Drug: Methotrexate; Drug: Placebo; Drug: Folic Acid Sponsor : Eli Lilly and Company Recruiting - verified November 2013